BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bates G, Van Hout MC, Teck JTW, McVeigh J. Treatments for people who use anabolic androgenic steroids: a scoping review. Harm Reduct J 2019;16:75. [PMID: 31888665 DOI: 10.1186/s12954-019-0343-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sharma A, Grant B, Islam H, Kapoor A, Pradeep A, Jayasena CN. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men. Best Pract Res Clin Endocrinol Metab 2022;:101691. [PMID: 35999138 DOI: 10.1016/j.beem.2022.101691] [Reference Citation Analysis]
2 Magnolini R, Falcato L, Cremonesi A, Schori D, Bruggmann P. Fake anabolic androgenic steroids on the black market - a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health 2022;22:1371. [PMID: 35842594 DOI: 10.1186/s12889-022-13734-4] [Reference Citation Analysis]
3 Bates G, Ralphs R, Bond VW, Boardley I, Hope V, Van Hout MC, McVeigh J. Systems mapping to understand complexity in the association between image and performance enhancing drugs (IPEDs) and harm. Int J Drug Policy 2022;107:103801. [PMID: 35858502 DOI: 10.1016/j.drugpo.2022.103801] [Reference Citation Analysis]
4 Amaral JMX, Kimergård A, Deluca P. Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis. BMJ Open 2022;12:e056445. [PMID: 35788077 DOI: 10.1136/bmjopen-2021-056445] [Reference Citation Analysis]
5 Ainsworth NP, Thrower SN, Petróczi A. Two sides of the same coin: A qualitative exploration of experiential and perceptual factors which influence the clinical interaction between physicians and Anabolic-Androgenic Steroid using patients in the UK. Emerging Trends in Drugs, Addictions, and Health 2022;2:100033. [DOI: 10.1016/j.etdah.2022.100033] [Reference Citation Analysis]
6 Griffiths S, Jotanovic D, Austen E. Androgen abuse among gay and bisexual men. Curr Opin Endocrinol Diabetes Obes 2021;28:589-94. [PMID: 34545842 DOI: 10.1097/MED.0000000000000684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bates G, Shepherd S, McVeigh J. Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare. Curr Opin Endocrinol Diabetes Obes 2021;28:630-5. [PMID: 34534148 DOI: 10.1097/MED.0000000000000676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Gagnon LR, Sadasivan C, Perera K, Oudit GY. Cardiac Complications of Common Drugs of Abuse: Pharmacology, Toxicology and Management. Can J Cardiol 2021:S0828-282X(21)00809-6. [PMID: 34737034 DOI: 10.1016/j.cjca.2021.10.008] [Reference Citation Analysis]
9 Bates G, Vinther AS. Applying insights from implementation and intervention science to improve the evidence base on image and performance-enhancing drugs (IPEDs) interventions. Performance Enhancement & Health 2021;9:100193. [DOI: 10.1016/j.peh.2021.100193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Chegeni R, Notelaers G, Pallesen S, Sagoe D. Aggression and Psychological Distress in Male and Female Anabolic-Androgenic Steroid Users: A Multigroup Latent Class Analysis. Front Psychiatry 2021;12:629428. [PMID: 34149470 DOI: 10.3389/fpsyt.2021.629428] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Zoob Carter BN, Boardley ID, van de Ven K. The Impact of the COVID-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids. Front Psychiatry 2021;12:636706. [PMID: 33828494 DOI: 10.3389/fpsyt.2021.636706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Atkinson AM, van de Ven K, Cunningham M, de Zeeuw T, Hibbert E, Forlini C, Barkoukis V, Sumnall HR. Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Australia in the HCP workforce. Int J Drug Policy 2021;95:103141. [PMID: 33549466 DOI: 10.1016/j.drugpo.2021.103141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
13 Handelsman DJ. Androgen Misuse and Abuse. Endocr Rev 2021;42:457-501. [PMID: 33484556 DOI: 10.1210/endrev/bnab001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
14 Albano GD, Amico F, Cocimano G, Liberto A, Maglietta F, Esposito M, Rosi GL, Di Nunno N, Salerno M, Montana A. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review. Healthcare (Basel) 2021;9:97. [PMID: 33477800 DOI: 10.3390/healthcare9010097] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
15 McCullough D, Webb R, Enright KJ, Lane KE, McVeigh J, Stewart CE, Davies IG. How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health. Rev Endocr Metab Disord 2021;22:389-405. [PMID: 33269425 DOI: 10.1007/s11154-020-09616-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
16 Ivanova B, Spiteller M. Stochastic dynamic mass spectrometric quantification of steroids in mixture — Part II. Steroids 2020;164:108750. [DOI: 10.1016/j.steroids.2020.108750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Amaral JMX, Padilha MC, Chagas SV, Baker JS, Mullen C, Vieira Neto L, Aquino Neto FR, Cruz MS. Effective treatment and prevention of attempted suicide, anxiety, and aggressiveness with fluoxetine, despite proven use of androgenic anabolic steroids. Drug Test Anal 2021;13:197-202. [PMID: 32808487 DOI: 10.1002/dta.2912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]